IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 68 filers reported holding IMMUNOCORE HLDGS PLC in Q2 2022. The put-call ratio across all filers is 1.69 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,406,457 | -1.9% | 65,635 | +13.3% | 0.02% | +8.7% |
| Q2 2023 | $3,473,903 | +228.0% | 57,937 | +170.5% | 0.02% | +283.3% |
| Q1 2023 | $1,059,054 | -77.9% | 21,421 | -74.5% | 0.01% | -78.6% |
| Q4 2022 | $4,792,910 | +101.5% | 83,983 | +65.7% | 0.03% | +115.4% |
| Q3 2022 | $2,379,000 | +51.8% | 50,688 | +20.7% | 0.01% | +30.0% |
| Q2 2022 | $1,567,000 | +7361.9% | 42,009 | +6006.0% | 0.01% | – |
| Q1 2022 | $21,000 | +10.5% | 688 | +37.6% | 0.00% | – |
| Q3 2021 | $19,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $28,523,073 | 25.19% |
| Velan Capital Investment Management LP | 200,000 | $9,888,000 | 8.43% |
| RTW INVESTMENTS, LP | 5,649,943 | $279,333,182 | 5.82% |
| Paradigm Biocapital Advisors LP | 1,126,256 | $55,682,097 | 5.28% |
| Rock Springs Capital Management LP | 3,001,662 | $148,402,169 | 3.54% |
| Logos Global Management LP | 500,000 | $24,720,000 | 3.54% |
| TANG CAPITAL MANAGEMENT LLC | 405,600 | $20,052,864 | 2.99% |
| GREAT POINT PARTNERS LLC | 255,367 | $12,625,344 | 2.48% |
| COWEN AND COMPANY, LLC | 405,174 | $20,031,802 | 2.35% |
| Eschler Asset Management LLP | 60,000 | $2,966,400 | 2.34% |